Hence, increasing PI3K/Akt activity and reducing the activation of COX-2 may underlie the potent anti-inflammatory impact of the treatment with insulin or Mg2+ in the T2DM. This evidence concerns the gene PTGS2 and type 2 diabetes mellitus.